The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Quantification of Myocardial Extracellular Volume Fraction in Systemic AL Amyloidosis: An Equilibrium Contrast Cardiovascular Magnetic Resonance Study
Abstract
Background—: Cardiac involvement predicts outcome in systemic AL amyloidosis and influences therapeutic options. Current methods of cardiac assessment do not quantify myocardial amyloid burden. We used equilibrium contrast cardiovascular magnetic resonance (EQ-CMR) to quantify the cardiac interstitial compartment, measured as myocardial extracellular volume (ECV) fraction, hypothesizing it would reflect amyloid burden. Methods and Results—: Sixty patients with systemic AL amyloidosis (65% men, median age 65 years) underwent conventional clinical cardiovascular magnetic resonance, including late enhancement, equilibrium contrast cardiovascular magnetic resonance, and clinical cardiac evaluation, including ECG, echocardiography, assays of N-terminal pro-brain natriuretic peptide and Troponin T, and functional assessment comprising the 6-minute walk test in ambulant individuals. Cardiac involvement in the amyloidosis patients was categorized as definite, probable, or none, suspected by conventional criteria. Findings were compared with 82 healthy controls. Mean ECV was significantly greater in patients than healthy controls (0.25 versus 0.40, P <0.001) and correlated with conventional criteria for characterizing the presence of cardiac involvement, the categories of none, probable, definite corresponding to ECV of 0.276 versus 0.342 versus 0.488, respectively ( P <0.001). ECV was correlated with cardiac parameters by echocardiography (eg, Tissue Doppler Imaging [TDI] S-wave R=0.52, P<0.001) and conventional cardiovascular magnetic resonance (eg, indexed left ventricular mass R =0.56, P <0.001). There were also significant correlations with N-terminal pro-brain natriuretic peptide ( R =0.69, P <0.001) and Troponin T ( R =0.53, P =0.006). ECV was associated with smaller QRS voltages ( R =0.57, P <0.001) and correlated with poorer performance in the 6-minute walk test ( R =0.36, P =0.03). Conclusions—: Myocardial ECV measurement has potential to become the first noninvasive test to quantify cardiac amyloid burden.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gertz, M. A., Comenzo, R., Falk, R. H., Fermand, J. P., Hazenberg, B. P., Hawkins, P. N., Merlini, G., Moreau, P., Ronco, P., Sanchorawala, V., et al. (2005) · American Journal of Hematology · doi:10.1002/ajh.20381 · Cited by 1,428
Self-citationPrimary systemic amyloidosis: clinical and laboratory features in 474 cases.
Kyle, R. A., & Ma, G. (1995) · PubMed · Cited by 1,255
Dispenzieri, A., Gertz, M. A., Kyle, R. A., Lacy, M. Q., Burritt, M. F., Therneau, T. M., Greipp, P. R., Witzig, T. E., Lust, J. A., Rajkumar, S. V., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.03.029 · Cited by 985
Cardiovascular Magnetic Resonance in Cardiac Amyloidosis
Maceira, A. M., Joshi, J., Prasad, S. K., Moon, J. C., Perugini, E., Harding, I., Sheppard, M. N., Poole-Wilson, P. A., Hawkins, P. N., & Pennell, D. J. (2005) · Circulation · doi:10.1161/01.cir.0000152819.97857.9d · Cited by 982
Self-citationFlett, A. S., Hayward, M. P., Ashworth, M. T., Hansen, M. S., Taylor, A. M., Elliott, P. M., McGregor, C., & Moon, J. C. (2010) · Circulation · doi:10.1161/circulationaha.109.930636 · Cited by 915
Self-citationPiechnik, S. K., Ferreira, V. M., Dall'Armellina, E., Cochlin, L. E., Greiser, A., Neubauer, S., & Robson, M. D. (2010) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/1532-429x-12-69 · Cited by 670
Ugander, M., Oki, A. J., Hsu, L.-Y., Kellman, P., Greiser, A., Aletras, A. H., Sibley, C. T., Chen, M. Y., Bandettini, W. P., & Arai, A. E. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr481 · Cited by 576
Variant-Sequence Transthyretin (Isoleucine 122) in Late-Onset Cardiac Amyloidosis in Black Americans
Jacobson, D. R., Pastore, R. D., Yaghoubian, R., Kane, I., Gallo, G., Buck, F. S., & Buxbaum, J. N. (1997) · New England Journal of Medicine · doi:10.1056/nejm199702133360703 · Cited by 554
Messroghli, D. R., Greiser, A., Fröhlich, M., Dietz, R., & Schulz‐Menger, J. (2007) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21119 · Cited by 353
Antibodies to human serum amyloid P component eliminate visceral amyloid deposits
Bodin, K., Ellmerich, S., Kahan, M. C., Tennent, G. A., Loesch, A., Gilbertson, J. A., Hutchinson, W. L., Mangione, P. P., Gallimore, J. R., Millar, D. J., et al. (2010) · Nature · doi:10.1038/nature09494 · Cited by 341
Self-citationElectrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement
Murtagh, B., Hammill, S. C., Gertz, M. A., Kyle, R. A., Tajik, A. J., & Grogan, M. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.10.028 · Cited by 330
Dispenzieri, A. A., Gertz, M. A., Kyle, R. A., Lacy, M. Q., Burritt, M. F., Therneau, T. M., McConnell, J. P., Litzow, M. R., Gastineau, D. A., Tefferi, A., et al. (2004) · Blood · doi:10.1182/blood-2004-01-0390 · Cited by 320
Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins
Dispenzieri, A., Kyle, R. A., Gertz, M. A., Therneau, T. M., Miller, W. L., Chandrasekaran, K., McConnell, J. P., Burritt, M. F., & Jaffe, A. S. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13396-x · Cited by 317
Electrophysiologic Abnormalities in AL (Primary) Amyloidosis With Cardiac Involvement
Reisinger, J., Dubrey, S. W., Lavalley, M., Skinner, M., & Falk, R. H. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00267-2 · Cited by 168
Characterising the myocardial interstitial space: the clinical relevance of non-invasive imaging
White, S. K., Sado, D. M., Flett, A. S., & Moon, J. (2012) · Heart · doi:10.1136/heartjnl-2011-301515 · Cited by 97
Self-citation
Cited by
Messroghli, D. R., Moon, J. C., Ferreira, V. M., Grosse-Wortmann, L., He, T., Kellman, P., Mascherbauer, J., Nezafat, R., Salerno, M., Schelbert, E. B., et al. (2016) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/s12968-017-0389-8 · Cited by 1,727
Self-citationMoon, J. C., Messroghli, D. R., Kellman, P., Piechnik, S. K., Robson, M. D., Ugander, M., Gatehouse, P. D., Arai, A. E., Friedrich, M. G., Neubauer, S., et al. (2013) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/1532-429x-15-92 · Cited by 1,136
Self-citationWechalekar, A. D., Gillmore, J. D., & Hawkins, P. N. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01274-x · Cited by 994
Self-citationCardiac T1 Mapping and Extracellular Volume (ECV) in clinical practice: a comprehensive review
Haaf, P., Garg, P., Messroghli, D. R., Broadbent, D. A., Greenwood, J. P., & Plein, S. (2016) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/s12968-016-0308-4 · Cited by 959
Taylor, A. J., Salerno, M., Dharmakumar, R., & Jerosch-Herold, M. (2016) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2015.11.005 · Cited by 563
Metadata
- Authors
- Banypersad, S. M., Sado, D. M., Flett, A. S., Gibbs, S. D. J., Pinney, J. H., Maestrini, V., Cox, A. T., Fontana, M., Whelan, C. J., Wechalekar, A. D., Hawkins, P. N., & Moon, J. C.
- Venue
- Circulation: Cardiovascular Imaging
- Published
- 2013-01
- Volume
- 6
- Issue
- 1
- Pages
- 34-39
- ISSN
- 1941-9651 (ISSN-L)
- 1942-0080
- OpenAlex
- W2548150178
- Cited by
- 335
- References
- 15
- FWCI
- 7.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.